−0.045 CAD
−300.00 K CAD
250.32 K CAD
7.81 M
About ENTHEON BIOMEDICAL CORP.
Sector
CEO
Timothy Ko
Headquarters
Vancouver
Website
Founded
2010
FIGI
BBG00KTGG545
Entheon Biomedical Corp. operates as a biotechnology research and development company. The firm engages in developing and commercializing dimethyltryptamine based psychedelic therapeutic products. Its therapies aim to treat addiction and substance use disorders. The company was founded on April 6, 2010 and is headquartered in Vancouver, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ENBI is 0.175 CAD — it has increased by 9.37% in the past 24 hours. Watch ENTHEON BIOMEDICAL CORP. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange ENTHEON BIOMEDICAL CORP. stocks are traded under the ticker ENBI.
ENBI stock has risen by 25.00% compared to the previous week, the month change is a 75.00% rise, over the last year ENTHEON BIOMEDICAL CORP. has showed a 75.00% increase.
ENBI reached its all-time high on Sep 22, 2016 with the price of 214.200 CAD, and its all-time low was 0.050 CAD and was reached on Dec 27, 2023. View more price dynamics on ENBI chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ENBI stock is 8.57% volatile and has beta coefficient of 3.48. Track ENTHEON BIOMEDICAL CORP. stock price on the chart and check out the list of the most volatile stocks — is ENTHEON BIOMEDICAL CORP. there?
Today ENTHEON BIOMEDICAL CORP. has the market capitalization of 1.51 M, it has increased by 25.93% over the last week.
Yes, you can track ENTHEON BIOMEDICAL CORP. financials in yearly and quarterly reports right on TradingView.
ENBI net income for the last quarter is −64.70 K CAD, while the quarter before that showed −94.56 K CAD of net income which accounts for 31.58% change. Track more ENTHEON BIOMEDICAL CORP. financial stats to get the full picture.
No, ENBI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ENTHEON BIOMEDICAL CORP. EBITDA is −322.12 K CAD, and current EBITDA margin is −124.96%. See more stats in ENTHEON BIOMEDICAL CORP. financial statements.
Like other stocks, ENBI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ENTHEON BIOMEDICAL CORP. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ENTHEON BIOMEDICAL CORP. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ENTHEON BIOMEDICAL CORP. stock shows the sell signal. See more of ENTHEON BIOMEDICAL CORP. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.